Financials
- Market Capitalization 249.4 M
- Employee 194
- Founded 2007
- CEO N/A
- Website www.akebia.com
- Headquarter Delaware, United States
- FIGI BBG000R33R00
- Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-10.36
Rapporto prezzo/fatturato
1.39
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3375 | ANIK Anika Therapeutics Inc. - Common Stock | 21.34 USD | -2.02% | -0.65% | +41.04% | +110.45% | 285.59 M USD | ||
| 3439 | EBS Emergent BioSolutions Inc. Common Stock | 5.18 USD | +1.77% | +15.62% | -29.52% | -51.68% | 265.60 M USD | ||
| 3532 | ACB Aurora Cannabis Inc. - Common Shares | 3.94 USD | 0.00% | +7.95% | +45.93% | -25.66% | 232.25 M USD | ||
| 3564 | DERM Journey Medical Corporation - Common Stock | 7.91 USD | +2.06% | +22.83% | +24.18% | +6.89% | 223.25 M USD |